NYSE:TOVX | Free Cash Flow | Theriva Biologics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2010-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.46M
2025-12-31-$2.88M$0.00-$2.88M
2025-03-31-$4.76M
2024-12-31-$4.69M$0.00-$4.69M
2024-03-31-$4.88M
2023-12-31-$6.54M$56,000.00-$6.6M
2023-03-31-$5.61M$8,000.00-$5.62M
2022-12-31-$5.37M$91,000.00-$5.46M
2022-03-31-$4.9M$0.00-$4.9M
2021-12-31-$4.81M$0.00-$4.81M
2021-03-31-$3.33M$14,000.00-$3.34M
2020-12-31-$3.13M$5,000.00-$3.14M
2020-03-31-$4.96M$0.00-$4.96M
2019-12-31-$3.61M$0.00-$3.61M
2019-03-31-$4.22M
2018-12-31-$3.29M$7,000.00-$3.3M
2018-03-31-$6.08M$0.00-$6.08M
2017-12-31-$3.93M$3,000.00-$3.94M-138.07%
2017-03-31-$6.01M$11,000.00-$6.02M
2016-12-31-$10.38M$370,000.00-$10.75M
2016-03-31-$5.67M$44,000.00-$5.72M
2015-12-31-$10.97M$44,000.00-$11.01M
2015-03-31-$5.46M$18,000.00-$5.48M
2014-12-31-$4.78M$5,000.00-$4.78M
2014-03-31-$3.47M$4,000.00-$3.47M
2013-12-31-$2.7M$11,000.00-$2.72M
2013-03-31-$1.66M$3,000.00-$1.67M
2012-12-31-$4.77M$3,000.00-$4.78M
2012-03-31-$1.42M$0.00-$1.42M
2011-12-31-$731,000.00$0.00-$731,000.00
2011-03-31-$281,000.00
2010-12-31-$665,212.00$9,930.00-$675,142.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$16.67M$35,000.00-$16.7M
2024-12-31-$16.94M$1,000.00-$16.94M
2023-12-31-$19M$202,000.00-$19.2M
2022-12-31-$19.08M$116,000.00-$19.2M
2021-12-31-$12.89M$14,000.00-$12.9M
2020-12-31-$12.17M$9,000.00-$12.18M
2019-12-31-$13.87M$0.00-$13.87M
2018-12-31-$17.28M$7,000.00-$17.29M
2017-12-31-$20.2M$212,000.00-$20.42M
2016-12-31-$27.9M$569,000.00-$28.47M
2015-12-31-$38.89M$501,000.00-$39.39M
2014-12-31-$16.08M$48,000.00-$16.13M
2013-12-31-$7.72M$36,000.00-$7.76M
2012-12-31-$8.92M$10,000.00-$8.93M
2011-12-31-$2.88M$0.00-$2.88M
2010-12-31-$1.15M$12,000.00-$1.16M